Stanislav Spanik
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Neutropenia and Cancer Infections
- Cancer Immunotherapy and Biomarkers
- Infectious Diseases top 5%
- Antifungal resistance and susceptibility
Papers in
- Oncology 40
- Neutropenia and Cancer Infections 28
- Colorectal Cancer Treatments and Studies 4
-
- Antifungal resistance and susceptibility 20
- Antimicrobial Resistance in Staphylococcus 5
- Co-authors
- Vladimir Krcmery (34 shared papers)Jan Trupl (29 shared papers)Alena Kunova (27 shared papers)Jozef Mardiak (20 shared papers)Michal Mego (11 shared papers)Daniela Světlovská (10 shared papers)Michal Chovanec (9 shared papers)Věra Miškovská (5 shared papers)
- Journals
- Chemotherapy (9 papers)Journal of Chemotherapy (7 papers)Supportive Care in Cancer (7 papers)Infection (4 papers)Annals of Oncology (3 papers)
- Partner nations
- SlovakiaUnited StatesMalaysia
In The Last Decade
Stanislav Spanik
78 papers receiving 2k citations
Peers
Comparison fields: 5 of 83
- Oncology 702
- Infectious Diseases 353
- Cancer Research 215
- Internal Medicine 33
- Molecular Medicine 62
Countries citing papers authored by Stanislav Spanik
This map shows the geographic impact of Stanislav Spanik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stanislav Spanik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stanislav Spanik more than expected).
Fields of papers citing papers by Stanislav Spanik
This network shows the impact of papers produced by Stanislav Spanik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stanislav Spanik. The network helps show where Stanislav Spanik may publish in the future.
Co-authors
The 25 scholars most cited alongside Stanislav Spanik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 469 | |
| 2 | 2015 | 200 | |
| 3 | 2015 | 134 | |
| 4 | 1998 | 88 | |
| 5 | 1999 | 83 | |
| 6 | 2018 | 79 | |
| 7 | 2017 | 70 | |
| 8 | 2005 | 52 | |
| 9 | 2023 | 50 | |
| 10 | 1997 | 49 | |
| 11 | 2009 | 44 | |
| 12 | 2015 | 42 | |
| 13 | 1998 | 38 | |
| 14 | 1997 | 35 | |
| 15 | 1997 | 34 | |
| 16 | 2018 | 32 | |
| 17 | 1996 | 26 | |
| 18 | 2014 | 25 | |
| 19 | 1998 | 22 | |
| 20 | 2017 | 22 |
About Stanislav Spanik
Stanislav Spanik is a scholar working on Oncology, Infectious Diseases, Cancer Research, Molecular Medicine and Surgery, having authored 86 papers that have together received 2k indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (28 papers), Antifungal resistance and susceptibility (20 papers), Testicular diseases and treatments (10 papers), Breast Cancer Treatment Studies (6 papers), Antimicrobial Resistance in Staphylococcus (5 papers), Colorectal Cancer Treatments and Studies (4 papers), Antibiotic Resistance in Bacteria (4 papers) and Bone health and osteoporosis research (2 papers). The work is most often cited by research in Oncology (702 citations), Infectious Diseases (353 citations), Cancer Research (215 citations), Internal Medicine (33 citations) and Molecular Medicine (62 citations). Stanislav Spanik has collaborated with scholars based in Slovakia, United States and Malaysia. Frequent co-authors include Vladimir Krcmery, Jan Trupl, Alena Kunova, Jozef Mardiak, Michal Mego, Daniela Světlovská, Michal Chovanec, Věra Miškovská, Katarína Rejleková and Eva Kukuckova. Their work appears in journals such as Chemotherapy, Journal of Chemotherapy, Supportive Care in Cancer, Infection and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.